Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John C. Reed currently holds 10,658 shares of ISIS PHARMACEUTICALS INC (ISIS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John C. Reed has been a net seller of ISIS stock. They have purchased $187.5K and sold $7.7M worth of shares.
John C. Reed's most recent insider trade was on Oct 17, 2025, when they sold 21,721 shares at $192.71 per share.
John C. Reed serves as Executive at ISIS PHARMACEUTICALS INC (ISIS). They have executed 19 insider transactions totaling $7.9M over their tenure at the company.
John C. Reed holds the position of Executive at ISIS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
John C. Reed has shown a selling trading pattern, with $187.5K in total purchases and $7.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John C. Reed was on Oct 17, 2025, when they sold $4.2M worth of JNJ shares. This transaction involved 21,721 shares at $192.71 per share.
John C. Reed currently owns 10,658 shares of ISIS PHARMACEUTICALS INC (ISIS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John C. Reed's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John C. Reed has 19 Form 4 filings on record as an insider at ISIS PHARMACEUTICALS INC.
Set alerts for John C. Reed and 40,000+ other insiders.